You are here
AusPAR: Adalimumab
Related information
Australian Public Assessment Report
3 December 2021
| AusPAR | |
|---|---|
| Active Ingredient | Adalimumab
|
| Product Name | Hulio
|
| Sponsor | Alphapharm Pty Limited
|
| Submission Number | PM-2020-01807-1-3
|
| Submission Type | New biosimilar medicine
|
| Decision | Approved
|
| AusPAR Date | 22 November 2021
|
| Publication Date | 3 December 2021 |